Psychiatry Investig.
2008 Jun;5(2):121-123. 10.4306/pi.2008.5.2.121.
Three Cases of Reversible Agranulocytosis after Treatment with Lamotrigine
- Affiliations
-
- 1Department of Psychiatry, and Behavioral Science, Seoul National University College of Medicine, Seoul, Korea. kys@snu.ac.kr
- KMID: 1706126
- DOI: http://doi.org/10.4306/pi.2008.5.2.121
Abstract
- Several psychotropic drugs, including clozapine, are known to cause agranulocytosis and this may lead to a fatal condition. Lamotrigine is an anticonvulsant that the Food and Drug Administration (FDA) has approved for the depression of bipolar disorder. A few cases of lamotrigine-induced agranulocytosis have been previously reported on, but the pathophysiology and clinical manifestations are not yet known. This case series reports on 3 patients with different medical conditions who experienced agranulocytosis during treatment with lamotrigine. In these cases, the agranulocytosis occurred a few weeks after initiation of lamotrigine and it rapidly disappeared after discontinuation. We also discuss several characteristics of lamotrigine-induced agranulocytosis.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Two Cases of Reversible Neutropenia Associated with Olanzapine-Valproate Combination Treatment
- Granulocyte-Colony Stimulating Factor(G-CSF) Treatment of Clozapine-induced Agranulocytosis
- Lamotrigine as an Augmentation Agent in Treatment-Resistant Bipolar Depression: A Case Report
- Levamisole-Induced Reversible Agranulocytosis in Children with Steroid Dependent Nephrotic Syndrome
- Lamotrigine and Lithium in the Treatment of Acute Bipolar Disorder
